Opinion: Big Pharma could boost its reputation with a solid response to Covid-19
President Trump, a known critic of Big Pharma, summoned 10 executives from various pharmaceutical companies to the White House in early March to discuss the coronavirus pandemic. He wanted the industry’s help in creating a vaccine to prevent the disease and therapies to fight it at a time when neither existed.
Trump’s behavior mimics that of most Americans. In times of medical crisis, we turn to those who can design, develop, and manufacture new medicines and ask, “What can Big Pharma discover to help save lives?”
